VYTRUS BIOTECH EO -01 (V5P) — Net Asset Quality Index
VYTRUS BIOTECH EO -01 (V5P) has a Net Asset Quality Index of 70.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €14.66 Million minus total liabilities of €4.35 Million yields net assets of €10.31 Million. A higher index indicates a stronger, lower-leverage balance sheet. See V5P days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
VYTRUS BIOTECH EO -01 Net Asset Quality Index Over Time (2021–2025)
This chart shows how VYTRUS BIOTECH EO -01's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 70.3%, representing net assets of €10.31 Million against total assets of €14.66 Million EUR. Explore VYTRUS BIOTECH EO -01 cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for VYTRUS BIOTECH EO -01 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for VYTRUS BIOTECH EO -01 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see V5P stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 70.3% | €10.31 Million | €14.66 Million | €4.35 Million | ▲ +4.8 pp |
| 2024 | 65.5% | €7.29 Million | €11.13 Million | €3.84 Million | ▲ +8.7 pp |
| 2023 | 56.8% | €5.29 Million | €9.31 Million | €4.02 Million | ▼ -2.6 pp |
| 2022 | 59.4% | €4.75 Million | €8.00 Million | €3.25 Million | ▲ +0.2 pp |
| 2021 | 59.2% | €4.25 Million | €7.18 Million | €2.93 Million | — |